flag flag  

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy

Description : Objective: To investigate the impact of 215 HIV-1 revertants on the risk of virological failure of the first thymidine analog-containing highly active antiretroviral therapy (HAART).Design: The study included 491 HIV-1 subjects of the Italian Cohort Naive for Anti retrovirals, 405 of whom received a...
Language(s) : Undetermined
Subject(s) : HIV-1 genotypic resistance, 215 revertants, nucleoside-associated mutations, HUMAN-IMMUNODEFICIENCY-VIRUS, HIGH-LEVEL RESISTANCE, DRUG-RESISTANCE, REVERSE-TRANSCRIPTASE, ZIDOVUDINE RESISTANCE, TYPE-1, MUTATIONS, INFECTION, TRANSMISSION, VARIANTS
Publisher(s) : LIPPINCOTT WILLIAMS & WILKINS
Contributor(s) :
Source(s) :
Publication Date(s) : 2004-01-23